Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-21
SponsorDuke University

About this trial

The purpose of this study is to test a new way of measuring the peripheral vision (called a visual field test) using a device which can be worn as goggles rather than being a large instrument the patient must sit at. This new visual field test (called VisuALL) is an FDA-approved virtual reality system which has been used in adults and children. This study will compare the performance of the VisuALL to the standard testing for peripheral vision, which is called the Humphrey Visual Field (HVF) test.

The study will recruit both healthy children, as well children and young adults who have eye conditions which require visual field testing as part of their standard care. The test will be performed on a day when the child or young adult already has a scheduled eye appointment as standard care. The test does not touch the eyes or require any eye drops to be given, and there is no known risk associated with the test itself. There may be a risk of loss of confidentiality. Participating in this study will require approximately 30 minutes, has no extra cost associated with it, and will be compensated by a parking pass for the day of the visit. There are no direct benefits for participants.

Selected participants will be also be given training and then loaned a home VisuALL system to allow home visual field testing. If your child is selected, additional information would be provided.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients must be at least four (4) years old

Cognitively normal (no developmental delay or syndrome)

Be able to tolerate wearing the virtual reality goggles for at least 10 minutes

Be able to provide informed consent of a parent/guardian (and assent if 12 years or older)

Disqualifiers

Developmental delay

Inability to obtain consent

Inability to understand English

Trial design

Design model

Parallel

Treatments tested in this trial

  • VisuALL

    Device

    Virtual Reality Visual Field Device

  • Humphrey Visual Field

    Device

    Standard of care Visual Field test

Treatment groups

1,000 Participants
are divided into 2 treatment groups
Group A: Patient (pathology) groupExperimental treatment 2 interventions
Group B: Control groupOther 1 intervention

Trial outcomes

Primary outcomes

1

Mean deviation results of visual field parameters

Mean deviation of the visual field is one score measured in decibels calculated from device reading

Time frame
During office visit, approximately 30 minutes
2

Pattern standard deviation results of visual field parameters

Pattern standard deviation of the visual field is one score calculated from device reading

Time frame
During office visit, approximately 30 minutes
3

Sensitivity results of visual field parameters

Sensitivities are the results of each space in the visual field measured in decibels

Time frame
During office visit, approximately 30 minutes

Secondary outcomes

1

Percent of times that scotomas were visualized as measured by visual field tests

Time frame
During office visit, approximately 30 minutes
2

Percent of participants stating satisfaction as measured by questionnaire

12 questions with strongly disagree to strongly agree

Time frame
During office visit, approximately 5 minutes
3

Percent of patients able to use VisuALL in-office testing as measured by patient observation

Time frame
During office visit, approximately 30 minutes
4

Percent of patients able to use VisuALL home testing as measured by device reading

Home testing will be done in a few patients that demonstrate facility with the device

Time frame
During office visit, 30 minutes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.